N4BP1 and neuroblastoma: Accordingly, by interacting with the de-ubiquitinating enzyme Cezanne, N4BP1 acts also as a potent negative regulator of nuclear factor-kappa B (NF-κB) signaling in neuroblastoma cells, a role that points to N4BP1 as a candidate target for immunotherapy [8].